[go: up one dir, main page]

BG29724A3 - Метод за получаване на кристална а-форма на празосин хидрохлорид - Google Patents

Метод за получаване на кристална а-форма на празосин хидрохлорид

Info

Publication number
BG29724A3
BG29724A3 BG035558A BG3555877A BG29724A3 BG 29724 A3 BG29724 A3 BG 29724A3 BG 035558 A BG035558 A BG 035558A BG 3555877 A BG3555877 A BG 3555877A BG 29724 A3 BG29724 A3 BG 29724A3
Authority
BG
Bulgaria
Prior art keywords
prazosin hydrochloride
obtaining crystalline
crystalline
hydrochloride
obtaining
Prior art date
Application number
BG035558A
Other languages
English (en)
Inventor
Ernest Bianco
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG29724A3 publication Critical patent/BG29724A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Метод за получаване на кристална алфа-форма на 2-/4-(2-фуроил) пиперазин-1-ил/-4-амино-6,7диметоксихиназолин хидрохлорид с формула.... Патентните претенции са формулирани в 3 точки.
BG035558A 1976-03-01 1977-03-01 Метод за получаване на кристална а-форма на празосин хидрохлорид BG29724A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (1)

Publication Number Publication Date
BG29724A3 true BG29724A3 (bg) 1981-01-15

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
BG035558A BG29724A3 (bg) 1976-03-01 1977-03-01 Метод за получаване на кристална а-форма на празосин хидрохлорид

Country Status (32)

Country Link
US (1) US4092315A (bg)
JP (1) JPS604188B2 (bg)
AR (1) AR210937A1 (bg)
AU (1) AU506937B2 (bg)
BE (1) BE851878A (bg)
BG (1) BG29724A3 (bg)
CA (1) CA1068269A (bg)
CH (1) CH618436A5 (bg)
CS (1) CS191332B2 (bg)
DD (1) DD129652A5 (bg)
DE (1) DE2708192C3 (bg)
DK (1) DK145858C (bg)
ES (1) ES8707447A1 (bg)
FI (1) FI62082C (bg)
FR (1) FR2372828A1 (bg)
GB (1) GB1538713A (bg)
HK (1) HK30881A (bg)
HU (1) HU173641B (bg)
IE (1) IE44522B1 (bg)
IL (1) IL51481A (bg)
LU (1) LU76868A1 (bg)
MY (1) MY8100271A (bg)
NL (1) NL169591C (bg)
NO (1) NO146499C (bg)
NZ (1) NZ183450A (bg)
PL (1) PL105559B1 (bg)
PT (1) PT66227B (bg)
RO (1) RO73095A (bg)
SE (1) SE423234B (bg)
SU (1) SU644387A3 (bg)
YU (1) YU41294B (bg)
ZA (1) ZA77918B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
CA2993152C (en) 2014-07-21 2022-12-13 Keir Manufacturing, Inc. Aerodynamic flyer bow

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents

Also Published As

Publication number Publication date
IL51481A (en) 1980-09-16
RO73095A (ro) 1981-06-26
JPS604188B2 (ja) 1985-02-01
ES545368A0 (es) 1978-06-01
DK145858C (da) 1983-09-12
SU644387A3 (ru) 1979-01-25
JPS52105206A (en) 1977-09-03
FR2372828B1 (bg) 1980-02-01
GB1538713A (en) 1979-01-24
FI62082C (fi) 1982-11-10
LU76868A1 (bg) 1977-09-21
FR2372828A1 (fr) 1978-06-30
DK145858B (da) 1983-03-21
CA1068269A (en) 1979-12-18
DE2708192A1 (de) 1977-09-08
IE44522L (en) 1977-09-01
HK30881A (en) 1981-07-10
ZA77918B (en) 1977-12-28
NO770674L (no) 1977-09-02
PL105559B1 (pl) 1979-10-31
AR210937A1 (es) 1977-09-30
SE7701624L (sv) 1977-09-02
BE851878A (fr) 1977-08-29
FI62082B (fi) 1982-07-30
YU41294B (en) 1987-02-28
AU506937B2 (en) 1980-01-31
HU173641B (en) 1979-07-28
NO146499B (no) 1982-07-05
PL196354A1 (pl) 1978-02-27
NL169591C (nl) 1982-08-02
NL7702123A (nl) 1977-09-05
DE2708192B2 (de) 1979-08-02
NL169591B (nl) 1982-03-01
NO146499C (no) 1982-10-13
CH618436A5 (bg) 1980-07-31
US4092315A (en) 1978-05-30
PT66227A (en) 1977-03-01
CS191332B2 (en) 1979-06-29
DK86877A (da) 1977-09-02
AU2244377A (en) 1978-11-23
IL51481A0 (en) 1977-04-29
PT66227B (en) 1978-07-14
YU49977A (en) 1983-12-31
MY8100271A (en) 1981-12-31
DD129652A5 (de) 1978-02-01
ES8707447A1 (es) 1987-08-16
SE423234B (sv) 1982-04-26
NZ183450A (en) 1979-03-16
IE44522B1 (en) 1981-12-30
FI770634A7 (bg) 1977-09-02
DE2708192C3 (de) 1980-05-08

Similar Documents

Publication Publication Date Title
BG29724A3 (bg) Метод за получаване на кристална а-форма на празосин хидрохлорид
BG28068A3 (bg) Метод за получаване на -3- хлорцефалоспорини
BG28849A3 (bg) Метод за получаване на гамапирони
BG34036A3 (bg) Метод за получаване на пропаргил -2- фениламино- имидазолини-(2) и техните присъединителни с киселина соли
BG35039A3 (bg) Метод за получаване на заместени хетероциклични феноксиамини
BG35596A3 (bg) Метод за получаване на 3,4-дихидро 2н -1, 2- бензотиазин-1, 1- двуокиси
BG28054A3 (bg) Метод за получаване на 2-(4-ароил-пиперазин-1-ил)-4-амино-6,7- диметоксихиназолини
BG35748A3 (bg) Метод за получаване на 2 4- (2- фуроил)- пиперзин- 1- ил- 4- амино- 6,7- диметоксихиназолин
BG28056A3 (bg) Метод за получаване на 5-амино-1,2,3-тиадиазол
BG28055A3 (bg) Метод за получаване на фенилпиперазинови производни
BG28064A3 (bg) Метод за получаване на 26-метан-2н-1-бензоксозини
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG34610A3 (bg) Метод за получаване на 2',6'-диалкил -n-(алкоксиметил)-2-хлорацетанилиди
BG33435A3 (bg) Метод за получаване на 6- метил- 8- (заместен) метилерголин
BG29646A2 (bg) 1,3-дизаместени карбамиди и 2- тиокарбамиди , метод за тяхното п получаване и приложението им
BG28716A3 (bg) Метод за получаване на ауранофин
BG28415A4 (bg) Метод за получаване на 9-хидроксиоктахидробензо(с) хинолини
BG33436A3 (bg) Метод за получаване на 4-дезацетол-viw-3- спиро-5"-оксазилидин-2",4-дион
DK158352C (da) Fremgangsmaade til fremstilling af 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydrochlorid
BG28062A3 (bg) Метод за получаване на 6а,10а-цис-хексахидродибензопираноли
BG35031A3 (bg) Метод за получаване на 1,1,2-трифенилпропанови (пропенови) производни
BG31948A3 (bg) Метод за получаване на фенил-2 индола
BG28848A3 (bg) Метод за получаване на 6-хлор-2 хлорметил- 4-фенил-хиназолин-3-окис
BG30926A3 (bg) Метод за получаване на n-(1-метил-2-пиролидинилметил-2,3-диметокси- 5-метилсулфамоилбензамид и негови производни
BG28045A4 (bg) Метод за получаване на октадиеннитрилни производни